3
Announcements
Trials
Browse
Landscape
Phase
Phase 2/3
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Myeloid
1
Conditions
Mastocytosis
1
Leukemia, Myeloid, Chronic-Phase
1
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
1
Leukemia
1
Interventions
masitinib
4
Imatinib Mesylate
3
midostaurin
1
fludarabine phosphate
1
fludarabine
1
avapritinib
1
Whole-Body Irradiation
1
Watchful Waiting
1
Transplantation
1
Tacrolimus
1
Stem Cell Transplantation
1
Sodium Chloride
1
Single-Cell Gene Expression Analysis
1
Radiotherapy
1
Phlebotomy
1
Peripheral Blood Stem Cell Transplantation
1
Mycophenolic Acid
1
Mass Screening
1
Injections
1
Hydroxychloroquine
1
Dasatinib
1
Cyclophosphamide
1
Cromolyn Sodium
1
Cladribine
1
Busulfan
1
BNT162 Vaccine
1
AK002
1
2019-nCoV Vaccine mRNA-1273
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Mastocytosis
×
Hydroxychloroquine
×
Myeloid
×
Clear all
NCT05084872
2021-10-20
HCQMa
University Hospital, Toulouse
Phase 2/3
Unknown
30 enrolled